Concurrent Radiotherapy and Triweekly Carboplatin for the Definitive Treatment of Locally Advanced Laryngeal Carcinoma

Conclusions:
In patients with LALC who are suboptimal candidates for high-dose cisplatin, our experience suggests that tCb AUC 5 with concurrent radiotherapy provides acceptable outcomes with tolerable toxicity.

Source: American Journal of Clinical Oncology - May 22, 2018 Category: Cancer & Oncology Tags: Original Articles: Head and Neck Source Type: research